<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/WebSite>
<http://www.genengnews.com/keywordsandtools/email/gen-news-highlights/bayer-plans-2012-filing-for-regorafenib-following-positive-phase-iii-mcrc-trial-results/25733/>